An Open Label Non-Interventional Evaluation of the Effect of Adjuvant Hormonal Treatment of Postmenopausal Women Wih Early Breast Cancer With Aromatase Inhibitors on Bone Mineral Density and Bone Fracture Rate in Daily Practice
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer|Osteoporosis
Sponsor: AstraZeneca